Evidence of a causal relationship between serum thyroid-stimulating hormone and osteoporotic bone fractures
European Thyroid Journal Aug 23, 2021
Soto-Pedre E, Siddiqui M, Mordi I, et al. - In large populations, electronic medical records linked to genomic data allow replication of genome-wide association study discoveries without additional genotyping costs. The outcomes illustrated that genetically raised serum thyroid-stimulating hormone (TSH) concentrations are causally correlated with reduced bone fracture risk in men.
According to the findings, replication in 9,452 euthyroid individuals confirmed known loci previously reported.
The results showed that 58 polymorphisms accounted for 11.08% of the TSH variation (p < 1e−04).
It was shown that TSH-GRS was directly correlated with the risk of hypothyroidism with an odds ratio (OR) of 1.98 for the highest quartile compared to the first quartile (p = 2.2e−12).
Furthermore, MR analysis of 5,599 individuals demonstrated that in comparison with those in the lowest tertile of the TSH-GRS, men in the highest tertile had a decreased risk of osteoporotic bone fracture (OR = 0.59, p = 2.4e−03), while no difference in a similar comparison was found in women (OR = 0.93, p = 0.61).
In addition,sensitivity analysis yielded similar outcomes.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries